UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

Macrophage colony-stimulating factor receptor/CD115+ non-classical monocytes are expanded in systemic lupus erythematosus and associated with lupus nephritis

Scandinavian journal of rheumatology, 2024-08, p.1

2024

Volltextzugriff (PDF)

Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

The Lancet (British edition), 2024-08, Vol.404 (10452), p.540-553

2024

Volltextzugriff (PDF)

Navigating the path of progress: The OMERACT 2023 emerging leaders program

Seminars in arthritis and rheumatism, 2024-06, Vol.66, p.152414-152414, Article 152414

2024

Volltextzugriff (PDF)

Efficacité et sécurité de l’iscalimab (un AcM anti-CD40) chez les patients atteints de maladie de Sjögren : résultats à 48 semaines d’un essai de phase 2b, randomisé et contrôlé par placebo (TWINSS)

La revue de medecine interne, 2024-06, Vol.45, p.A58-A59

2024

Volltextzugriff (PDF)

Modulation dose-dépendante des signatures protéomiques par le ianalumab chez les patients atteints de la maladie de Sjögren

La revue de medecine interne, 2024-06, Vol.45, p.A56-A57

2024

Volltextzugriff (PDF)

Résultats de phase 2 d’efficacité et de tolérance jusqu’à 52 semaines du ianalumab, anti-BAFF récepteur (BAFF-R), chez les patients atteints de lupus érythémateux systémique (LES)

La revue de medecine interne, 2024-06, Vol.45, p.A122-A123

2024

Volltextzugriff (PDF)

Field demonstration analyzing the implementation of individual animal electronic identification and genetic testing in western range sheep flocks

PloS one, 2023-08, Vol.18 (8), p.e0290281-e0290281

2023

Volltextzugriff (PDF)

Timing of the Transition From Sevier‐ to Laramide‐Style Tectonism in Southwestern Montana Based on the Provenance of the Frontier Formation, North American Cordillera

Tectonics (Washington, D.C.), 2023-08, Vol.42 (8), p.n/a

2023

Volltextzugriff (PDF)

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet. Rheumatology, 2023-06, Vol.5 (6), p.e341-e350

2023

Volltextzugriff (PDF)

Limits of Detection for EXAFS Characterization of Heterogeneous Single-Atom Catalysts

ACS catalysis, 2023-05, Vol.13 (9)

2023

Volltextzugriff (PDF)

Limits of Detection for EXAFS Characterization of Heterogeneous Single-Atom Catalysts

ACS catalysis, 2023-05, Vol.13 (9), p.6462-6473

2023

Volltextzugriff (PDF)

Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex

Brain (London, England : 1878), 2023-04, Vol.146 (4), p.1436-1452

2023

Volltextzugriff (PDF)

Combinatorial synthesis of a hyaluronan based polysaccharide library for enhanced CD44 binding

Carbohydrate polymers, 2023-01, Vol.300, p.120255-120255, Article 120255

2023

Volltextzugriff (PDF)

Field demonstration analyzing the implementation of individual animal electronic identification and genetic testing in western range sheep flocks

PloS one, 2023-01, Vol.18 (8)

2023

Volltextzugriff (PDF)

Preface

CEUR workshop proceedings, 2023, Vol.3475

2023

Volltextzugriff (PDF)

Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial

The Lancet. Rheumatology, 2023-01, Vol.5 (1), p.e14-e23

2023

Volltextzugriff (PDF)

Foreland basin response to Middle Cretaceous thrust belt evolution, southwestern Montana, USA

Geosphere (Boulder, Colo.), 2022-12, Vol.18 (6), p.1783-1803

2022

Volltextzugriff (PDF)

Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis

Archiv der Pharmazie (Weinheim), 2022-09, Vol.355 (9), p.e2200095-n/a

2022

Volltextzugriff (PDF)

Design of high-temperature syntheses for cluster compounds (Bi 2 x A 1−3 x )[PtBi 6 I 12 ] with A = Mn, Fe, Sn, Pb

Acta crystallographica. Section A, Foundations and advances, 2022-08, Vol.78 (a2), p.e104-e104

2022

Volltextzugriff (PDF)

Unlocking New Redox Activity in Alluaudite Cathodes through Compositional Design

Chemistry of materials, 2022-05, Vol.34 (9), p.4088-4103

2022

Volltextzugriff (PDF)

Middle Albian provenance, sediment dispersal and foreland basin dynamics in southwestern Montana, North American Cordillera

Basin research, 2022-04, Vol.34 (2), p.913-937

2022

Volltextzugriff (PDF)

Structure-Based Design and Biological Evaluation of Novel Caspase‑2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314

ACS pharmacology & translational science, 2022-01, Vol.5 (1), p.20-40

2022

Volltextzugriff (PDF)

Structural Characterization of the Human Cytosolic Malate Dehydrogenase I

ACS omega, 2022-01, Vol.7 (1), p.207-214

2022

Volltextzugriff (PDF)

A thermal profile across the Idaho-Montana fold-thrust belt reveals a low-relief orogenic wedge that developed atop a pre-orogenic basement high

Lithosphere, 2022, Vol.2022 (1)

2022

Volltextzugriff (PDF)

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Macrophage colony-stimulating factor receptor/CD115+ non-classical monocytes are expanded in systemic lupus erythematosus and associated with lupus nephritis

Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

Navigating the path of progress: The OMERACT 2023 emerging leaders program

Efficacité et sécurité de l’iscalimab (un AcM anti-CD40) chez les patients atteints de maladie de Sjögren : résultats à 48 semaines d’un essai de phase 2b, randomisé et contrôlé par placebo (TWINSS)

Modulation dose-dépendante des signatures protéomiques par le ianalumab chez les patients atteints de la maladie de Sjögren

Résultats de phase 2 d’efficacité et de tolérance jusqu’à 52 semaines du ianalumab, anti-BAFF récepteur (BAFF-R), chez les patients atteints de lupus érythémateux systémique (LES)

Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial

Field demonstration analyzing the implementation of individual animal electronic identification and genetic testing in western range sheep flocks

Timing of the Transition From Sevier‐ to Laramide‐Style Tectonism in Southwestern Montana Based on the Provenance of the Frontier Formation, North American Cordillera

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

Limits of Detection for EXAFS Characterization of Heterogeneous Single-Atom Catalysts

Limits of Detection for EXAFS Characterization of Heterogeneous Single-Atom Catalysts

Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex

Combinatorial synthesis of a hyaluronan based polysaccharide library for enhanced CD44 binding

Field demonstration analyzing the implementation of individual animal electronic identification and genetic testing in western range sheep flocks

Preface

Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial

Foreland basin response to Middle Cretaceous thrust belt evolution, southwestern Montana, USA

Characterization of caspase‐2 inhibitors based on specific sites of caspase‐2‐mediated proteolysis

Design of high-temperature syntheses for cluster compounds (Bi 2 x A 1−3 x )[PtBi 6 I 12 ] with A = Mn, Fe, Sn, Pb

Unlocking New Redox Activity in Alluaudite Cathodes through Compositional Design

Middle Albian provenance, sediment dispersal and foreland basin dynamics in southwestern Montana, North American Cordillera

Structure-Based Design and Biological Evaluation of Novel Caspase‑2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314

Structural Characterization of the Human Cytosolic Malate Dehydrogenase I

A thermal profile across the Idaho-Montana fold-thrust belt reveals a low-relief orogenic wedge that developed atop a pre-orogenic basement high

Suchergebnisse filtern